City Therapeutics, Inc. Common Stock (CTY) is a publicly traded the market company. As of October 19, 2026, CTY trades at $21.44 with a market cap of $1.13B and a P/E ratio of 0.00. CTY moved -4.02% today. Year to date, CTY is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $20.50 to $23.88. Rallies surfaces CTY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
City Therapeutics, Inc. Common Stock (CTY) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. CTY moved -4.02% today.
| Metric | Value |
|---|---|
| Price | $21.44 |
| Market Cap | $1.13B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.37% |
| 52-Week High | $23.88 |
| 52-Week Low | $20.50 |
| Volume | 279.41K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
CTY analyst coverage data. Average price target: $0.00.